Cheat sheet
OPRA Exam Cheat Sheet
Biomedical Sciences
- 20% of exam
- Physiology & Pathophysiology Microbiology & Immunology Electrolytes Disease States
Medicinal Chemistry & Biopharmaceutics
- 10% of exam
- Formulation & Drug Delivery Drug Stability Solubility Pharmaceutical Microbiology
Pharmacokinetics & Pharmacodynamics
- 10% of exam
- ADME Half-Life & Clearance Receptor Theory Dose-Response
Pharmacology & Toxicology
- 15% of exam
- Adverse Drug Reactions Drug Interactions Antidotes Mechanism of Action
Therapeutics & Patient Care
- 45% of exam
- PBS & Dispensing Medicine Scheduling Counselling & Safety Law & Ethics Special Populations
Quick Facts
- Exam OPRA
- Body APC / Pearson VUE
- Questions 120 (90% scored)
- Time 150 min
- Result Pass / Unsuccessful
- Fee AU$2,245 (2026)
- Format Closed-book, CBT
- Blueprint March 2025 launch
Physiology & Pathophysiology BI
- Homeostasis Stable internal balance
- Negative feedback Reverses change, restores balance
- Sepsis criteria qSOFA or SIRS markers
- Acid-base balance pH, CO2, bicarbonate control
- Electrolyte imbalance Na, K, Ca disturbance
- Inflammation markers CRP, ESR, WCC
Microbiology & Immunology BI
- Gram stain Positive purple, negative pink
- Innate immunity Fast, non-specific defence
- Adaptive immunity Specific, memory-based response
- Antibiotic resistance Beta-lactamase, efflux, target change
- Vaccine types Live, inactivated, subunit, mRNA
Formulation & Drug Delivery ME
- Bioavailability Fraction reaching systemic circulation
- First-pass metabolism Liver reduces oral bioavailability
- Enteric coating Delays release until intestine
- Sustained release Slow, prolonged drug release
- Solubility factors pH, particle size, temperature
- Drug stability Resists degradation over time
Pharmaceutical Microbiology & QC ME
- Sterility testing Confirms no microbial contamination
- Preservatives Prevent microbial growth
- Aseptic technique Prevents contamination during compounding
- Endotoxin limit Pyrogen safety threshold
ADME Order PK
- Absorption, Distribution, Metabolism, Excretion — in sequence
- A: gut/site uptake D: spreads through tissues M: liver transforms drug E: kidney/bile removes drug
Zero-Order vs First-Order Kinetics PK
Zero-order kinetics
- Constant amount eliminated
- Rate independent of concentration
First-order kinetics
- Constant fraction eliminated
- Rate depends on concentration
- Fixed amount vs fixed fraction
Pharmacokinetics Core PK
- ADME Absorption, distribution, metabolism, excretion
- Half-life Time to halve concentration
- Volume of distribution Apparent body drug spread
- Clearance Volume cleared per time
- Steady state ~5 half-lives to reach
- Loading dose Fast target concentration achieved
- Zero-order kinetics Constant amount eliminated
- First-order kinetics Constant fraction eliminated
Agonist vs Antagonist PK
Agonist
- Binds, activates receptor
- Produces a response
Antagonist
- Binds, blocks receptor
- No response produced
- Turns on vs turns off
Pharmacodynamics Core PK
- Agonist Activates receptor response
- Antagonist Blocks receptor response
- Therapeutic index Toxic dose over effective dose
- ED50 Effective dose in 50%
- Tolerance Reduced response, repeated exposure
- Dose-response curve Effect size versus dose
Type A vs Type B ADR PH
Type A ADR
- Dose-related, predictable
- Common, extension of effect
Type B ADR
- Not dose-related
- Rare, idiosyncratic or allergic
- Predictable vs unpredictable reaction
Antidote Picker PH
- Paracetamol overdose → N-acetylcysteine
- Opioid overdose/respiratory depression → Naloxone
- Benzodiazepine overdose → Flumazenil ( Rarely used, seizure risk )
- Warfarin overdose/bleeding → Vitamin K
- Iron overdose → Desferrioxamine
- Organophosphate/nerve agent exposure → Atropine
ADRs & Drug Interactions PH
- Type A ADR Predictable, dose-related reaction
- Type B ADR Unpredictable, idiosyncratic reaction
- CYP450 inhibitor Raises interacting drug levels
- CYP450 inducer Lowers interacting drug levels
- Serotonin syndrome SSRI + MAOI risk
- QT prolongation Risk of torsades de pointes
Toxicology & Antidotes PH
- Paracetamol overdose Antidote: N-acetylcysteine
- Opioid overdose Antidote: naloxone
- Benzodiazepine overdose Antidote: flumazenil
- Warfarin overdose Antidote: vitamin K
- Iron overdose Antidote: desferrioxamine
- Organophosphate poisoning Antidote: atropine
Scheduling Ladder TH
- S2 to S8: control increases with each schedule
- S2: pharmacy self-select S3: pharmacist supply only S4: prescription required S8: controlled, high risk
S3 vs S4 Scheduling TH
S3 Pharmacist Only
- No script needed
- Pharmacist supply + advice
S4 Prescription Only
- Script required
- Prescriber authorises use
- Pharmacist supply vs prescriber required
Medicine Scheduling Picker TH
- Self-selected, pharmacist advice available → S2 Pharmacy Medicine
- Needs pharmacist supply, no script → S3 Pharmacist Only
- Needs doctor's prescription → S4 Prescription Only
- High addiction/abuse potential → S8 Controlled Drug
- Banned from general sale → S9 Prohibited Substance
- Uncertain schedule → Check current SUSMP
PBS & Dispensing TH
- PBS Subsidises listed prescription medicines
- General co-payment Up to AU$25 (2026)
- Concessional co-payment AU$7.70 per script (2026)
- Safety Net threshold AU$1,748.20 general (2026)
- Concessional Safety Net AU$277.20 threshold (2026)
- Authority prescription Needs PBS approval first
- Repeats Authorised refills without new script
PBS Safety Net Order TH
- Co-payment first, then Safety Net threshold, then reduced cost
- Pay co-payment each script Reach annual threshold amount Concession: free after threshold General: cheaper after threshold
OPRA vs KAPS TH
OPRA (current, 2025+)
- 120 MCQs, 150 minutes
- Clinical judgement emphasis
- Therapeutics weighted 45%
KAPS (retired 2024)
- Legacy knowledge-only exam
- Less patient-care weighting
- OPRA current; KAPS retired
PBS Supply Picker TH
- Concession card holder → Concessional co-payment applies
- General patient, no card → General co-payment applies
- Restricted PBS indication → Authority prescription required
- Repeat needed, script allows → Dispense authorised repeat
- Patient nears Safety Net → Track cumulative PBS spend
- Non-PBS item requested → Private/full price script
Scheduling: SUSMP & Poisons Standard TH
- S2 Pharmacy Medicine, self-selection
- S3 Pharmacist Only, no script
- S4 Prescription Only Medicine
- S8 Controlled Drug, addiction risk
- S9 Prohibited substance
- SUSMP TGA Poisons Standard document
Five Competency Domains TH
- Professionalism, Communication, Medicines, Leadership, Education — five domains
- D1: professionalism and ethics D2: communication and collaboration D3: medicines management, patient care D4: leadership and management D5: education and research
AHPRA vs Pharmacy Board TH
AHPRA
- National registration body
- Handles notifications, all professions
Pharmacy Board of Australia
- Sets pharmacist practice standards
- Profession-specific decisions
- Registers everyone vs sets standards
Law, Ethics & Regulators TH
- AHPRA National registration + notifications body
- Pharmacy Board of Australia Sets pharmacist practice standards
- National Law Health practitioner regulation legislation
- Mandatory notification Reports impairment, misconduct, risk
- Code of conduct Professional behaviour expectations
- Provisional registration Intern pharmacist pathway status
General vs Concessional Co-payment TH
General co-payment
- Up to AU$25
- No concession card
Concessional co-payment
- Fixed AU$7.70
- Concession card required
- Card status sets the fee
Counselling & Patient Safety TH
- CMI Consumer Medicine Information leaflet
- MedsCheck Community pharmacy medicine review
- HMR Home Medicines Review, GP-referred
- DAA/Webster pack Dose administration aid
- Health literacy Ability to understand health information
- Adherence Following agreed treatment plan
Special Populations & Harm Minimisation TH
- Pregnancy categories A to X risk scale
- Renal dose adjustment Based on eGFR/CrCl
- Paediatric dosing Weight-based, mg/kg calculation
- Opioid substitution therapy Methadone or buprenorphine treatment
- Needle and syringe program Reduces blood-borne virus spread
- Elderly high-risk medicines Anticholinergics, sedatives, falls risk
Common Traps
OPRA ≠ KAPS
- OPRA is current 2025+ exam ≠ KAPS retired November 2024
S3 ≠ S4 scheduling
- S3 needs no script ≠ S4 needs a prescription
AHPRA ≠ Pharmacy Board
- AHPRA runs registration admin ≠ Board sets practice standards
General ≠ concessional co-payment
- General up to AU$25 ≠ Concession fixed at AU$7.70
Scored ≠ unscored questions
- 90% of items scored ≠ 10% unscored, uncounted trial
Zero-order ≠ first-order kinetics
- Zero-order: fixed amount removed ≠ First-order: fixed fraction removed
Type A ≠ Type B ADR
- Type A dose-related, predictable ≠ Type B idiosyncratic, unpredictable
Last Minute
- 1. 120 MCQs, 150 minutes total
- 2. 90% scored, 10% unscored trial
- 3. Therapeutics and patient care: 45%
- 4. Biomedical sciences weighted at 20%
- 5. Pharm/tox weighted at 15%
- 6. PK/PD and chemistry each 10%
- 7. Result is pass or unsuccessful
- 8. No published fixed pass mark
- 9. S3 no script, S4 needs script
- 10. AHPRA registers; Board sets standards
- 11. General co-pay ~AU$25, concession AU$7.70
- 12. OPRA replaced KAPS, March 2025
Overseas Pharmacist Readiness Assessment (OPRA)
- Practice Questions 142 questions Study Guide 35 topics Cheat Sheet 78 facts Flashcards 50 cards Podcast